Report for Riley RF

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (1)

Title : Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease - Riley_2009_IDrugs_12_648
Author(s) : Riley RF , Corson MA
Ref : IDrugs , 12 :648 , 2009
Abstract : Riley_2009_IDrugs_12_648
ESTHER : Riley_2009_IDrugs_12_648
PubMedSearch : Riley_2009_IDrugs_12_648
PubMedID: 19790016